|
|
Blood, 1 July 2007, Vol. 110, No. 1, pp. 161-170.
Prepublished online as a Blood First Edition Paper on March 23, 2007; DOI 10.1182/blood-2006-10-050476.
 Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor–mediated cell signaling
Samir K. Mandal1,
Usha R. Pendurthi1, and
L. Vijaya Mohan Rao1
1 Biomedical Research Division, The University of Texas Health Science Center at Tyler
Tissue factor (TF) is the cellular receptor for clotting factor VIIa (FVIIa), and the formation of TF-FVIIa complexes on cell surfaces triggers the activation of the coagulation cascade and the cell signaling. Our recent studies have shown that a majority of TF resides in various intracellular compartments, predominantly in the Golgi, and that FVIIa binding to cell surface TF induces TF endocytosis and mobilizes the Golgi TF pool to translocate it to the cell surface. This present study is aimed to elucidate the mechanisms involved in TF endocytosis and its mobilization from the Golgi. Activation of protease-activated receptor 1 (PAR1) and PAR2 by specific peptide agonists and proteases, independent of FVIIa, mobilized TF from the Golgi store and increased the cell surface expression of TF. Blocking PAR2 activation, but not PAR1, with neutralizing antibodies fully attenuated the FVIIa-induced TF mobilization. Consistent with these data, silencing the PAR2 receptor, and not PAR1, abrogated the FVIIa-mediated TF mobilization. In contrast to their effect on TF mobilization, PAR1 and PAR2 activation, in the absence of FVIIa, had no effect on TF endocytosis. However, PAR2 activation is found to be critical for the FVIIa-induced TF endocytosis. Overall the data herein provide novel insights into the role of PARs in regulating cell surface TF expression.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
I. Lopez-Vilchez, M. Diaz-Ricart, J. G. White, G. Escolar, and A. M. Galan
Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake
Cardiovasc Res,
November 1, 2009;
84(2):
309 - 316.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. C. Nayak, P. Sen, S. Ghosh, R. Gopalakrishnan, C. T. Esmon, U. R. Pendurthi, and L. V. M. Rao
Endothelial cell protein C receptor cellular localization and trafficking: potential functional implications
Blood,
August 27, 2009;
114(9):
1974 - 1986.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. R. Hercus, D. Thomas, M. A. Guthridge, P. G. Ekert, J. King-Scott, M. W. Parker, and A. F. Lopez
The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease
Blood,
August 13, 2009;
114(7):
1289 - 1298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Mattes, R. M. Sharkey, H. Karacay, M. S. Czuczman, and D. M. Goldenberg
Therapy of Advanced B-Lymphoma Xenografts with a Combination of 90Y-anti-CD22 IgG (Epratuzumab) and Unlabeled Anti-CD20 IgG (Veltuzumab)
Clin. Cancer Res.,
October 1, 2008;
14(19):
6154 - 6160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. R. Pendurthi, S. Ghosh, S. K. Mandal, and L. V. M. Rao
Tissue factor activation: is disulfide bond switching a regulatory mechanism?
Blood,
December 1, 2007;
110(12):
3900 - 3908.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
